Navigation Links
Blunted by Roy Blunt: The Billboard the Congressman Doesn't Want You to See
Date:8/13/2009

SPRINGFIELD, Mo., Aug. 13 /PRNewswire-USNewswire/ -- As the debate over health care reform heats up, an effort to place a billboard in U.S. Rep. Roy Blunt's home district has been, well, blunted.

The billboard was to have featured a picture of Blunt with the words: "Roy Blunt has taken $556,682 in contributions from the insurance industry. Is that why he won't take our side on health care reform?"

USAction and its Missouri affiliate, Missouri Progressive Vote Coalition, had arranged to place the billboard in downtown Springfield. However, the groups were informed Thursday that it was being rejected based on political content.

"Roy Blunt, the target of this smear campaign, is a local politician and has been a strong proponent of Outdoor Advertising in Missouri for a number of years," Lamar Advertising Company said in an email message. "As much as we would always love the business, we will have to respectfully decline."

The move comes after Blunt tried, and failed, to have a radio spot taken off the air pointing out that the senior Republican congressman has taken more than half a million dollars worth of campaign contributions from the insurance industry and is working to defeat health care reform. A second radio ad - currently running on four Springfield stations -- also points out that Blunt has questioned the worthiness of Medicare.

USAction Program Director Alan Charney said alternate plans are being made to get the word out about Blunt's connections to the insurance industry and refusal to support quality, affordable health care for his constituents. "We're guessing that there are newspapers in Congressman Blunt's district that would welcome our business and won't discriminate based on content," Charney said.

Julie Burkhart, executive director of Missouri Progressive Vote Coalition, added that Blunt should stand up for hi
'/>"/>

SOURCE USAction
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Blunt: On PEPFAR, Majority Attempts to Spend in Five Years What CBO Says It Cant in 10
2. Blunt: Trustees Report is a Reminder of Medicare and Social Security Crisis
3. Blunt: House Republicans Fight to Ensure Taxpayer Resources Arent Used to Fund Abortions Overseas
4. Blunt: Democrats Flawed Spending Compromise
5. Blunt: New SCHIP Bill Addresses None of the Problems With the Old
6. Blunt: House Sustains Presidents Veto, Now Lets Get to Work on Genuine Solution
7. Blunt: Time to Stop the Politics on SCHIP, and Start the Negotiations
8. Hospital Caregivers Unveil Billboards Calling for Improved Patient Care, Quality Jobs at Community Medical Centers
9. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
10. Detroit Branch NAACP President, Rev. Dr. Wendell Anthony, Denounces Congressman Thaddeus McCotters Resolution
11. Congressman Jerry McNearney (D-Calif.) becomes 76th Co-Sponsor of H.R. 22
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Veinwave Eliminates Spider Veins and Telangiectasia , ... (PRWEB) December 10, 2009 ... and telangiectasia – those unsightly clusters of red, blue or ... In fact, for Western populations like the US, it’s been estimated that ... , , , , ,Although the Veinwave has been ...
(Date:12/15/2009)... Ill. A study in the Dec. 15 ... Medicine indicates that significant associations exist between ... regurgitation and headaches in young school-aged children. ... parent-reported insomnia was 3.3 times more likely in ... likely in children with headaches. Nineteen percent ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... 14 Americold Realty Trust ("Americold") announced today ... S-11 with the U.S. Securities and Exchange Commission (the ... its common shares. The number of shares to be ... not yet been determined. The common shares to be ... by Americold. ,, The joint book-running managers of ...
(Date:12/14/2009)... WASHINGTON, Dec. 14 The National Organization for ... an immediate end to lifetime and annual health insurance ... Politico, a newspaper distributed widely on Capitol Hill, ... loopholes that would allow caps to continue for most ... "NORD supports health care reform and welcomes the promises ...
Breaking Medicine News(10 mins):Health News:Vein Center & CosMed, Inc. Selected as Exclusive St. Louis Provider of FDA-Cleared Device 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Americold Realty Trust Files Registration Statement for Proposed Initial Public Offering 2Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2
... prisoners has failed to solve the crisis that is ... the BMA today. ,The 19th July marks ... introduction of emergency measures designed to alleviate the overcrowding ... of the Government strategy was an early release programme ...
... a long-standing belief that male circumcision can reduce HIV ... AIDS conference will be told next week . ... Society (IAS) conference to be held in Sydney from ... major development in HIV prevention. ,"We always ...
... a product recall in US without a Chinese link. Following ... a Georgia facility are being withdrawn in USA. ... canned foods in nearly four decades. ,Health officials ... leading brands like Castleberry's, Kroger and Austex . ...
... rise in the number of Australian HIV cases in the ... risky sexual behaviour in men having sex with men, and ... emerge, according to research published online for the Medical Journal ... Professor of Epidemiology at the National Centre in HIV Epidemiology ...
... Some chain-smokers are reluctant or incapable of quitting smoking, but ... they smoke each day . ,However, after studying ... very little attention has been given to this alternative of ... effort in therapies aimed at smokers has been at helping ...
... non-pyrethroid insecticide, propoxur, and a repellent, N,N-diethyl toluamide ... synergy against mosquitoes responsible for malaria transmission to ... had proved to be much more effective than ... nets soaked with this mixture had a lethal ...
Other Medicine News:Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2Health News:Male Circumcision can Cut HIV Infection, Studies Show 2Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 2Health News:Chilly Sauce Linked to Botulism, Forcing Recall in US 3Health News:HIV Cases Increasing In Australia 2Health News:Chain Smokers Prepared to Lessen Their Daily Cigs Rather Than Quitting 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2
(Date:12/14/2009)... Calif., Dec. 14 The Roberts ... today released the analysis of social responsibility ... world-wide. The report contains a compilation of ... environmental and social reporting of the companies. ... and performance for both environmental and social ...
(Date:12/14/2009)... According to Millennium Research Group ... market intelligence, Japan,s complex regulatory environment and ... significant lag in peripheral vascular stenting device ... developed nations. MRG,s new Japanese ... report finds, however, that recent indication-specific device ...
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) ... Suspension for the treatment of schizophrenia in adults, ... ) announced today. ZYPREXA RELPREVV, a long-acting intramuscular ... to four weeks. ,, Different from both oral ... allow for stable concentrations of the active drug ...
Breaking Medicine Technology:New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 2New Report Grades Sustainability Reporting of Top Pharmaceutical Companies 3Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 2Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8FamilyLife Supports Military Marriages in Atlanta 62459 1FamilyLife Supports Military Marriages in Atlanta 62459 2Ministerial Roundtable Discusses Future of Medical Tourism 62455 1Ministerial Roundtable Discusses Future of Medical Tourism 62455 2Ministerial Roundtable Discusses Future of Medical Tourism 62455 3Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 1Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 2Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 3Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 4Peregrine Completes Patient Enrollment in Cotara 28R 29 Dose Confirmation and Dosimetry Brain Cancer Trial 15048 5
... England, December 8 , ... Completed Price and,Reimbursement Approval for Tetrabenazine in H1 2009 ... Distribution Rights Granted in Finland (MediFront) and Taiwan,(Giddi Pharma); ... Cambridge Laboratories Limited ...
... 7 Millennium: The Takeda Oncology,Company today ... randomized, multi-center,Company-sponsored Phase I/II study of VELCADE, ... previously untreated multiple,myeloma (MM). The preliminary analysis ... of four drugs was generally well tolerated ...
Other Medicine Technology:Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 2Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6
... monoclonal antibody based colorimetric test intended ... gonorrhoeae. The test requires less than ... heating or pretreatment. The test does ... cultures. GonoGen&trade II eliminates agglutination, guesswork, ...
... a monoclonal antibody based coagglutination ... identification of Neisseria gonorrhoeae. The ... viable or fresh cultures. After ... minute rotation, a positive reaction ...
Rapid Test Kit...
... a novel device for the growth ... and Neisseria meningitidis. This product ... is easily transportable as a self-contained ... and examine the growth of organisms ...
Medicine Products: